- Home
- WRLD vs MDXG Comparison
WRLD vs MDXG Comparison
Compare WRLD & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRLD
- MDXG
- Stock Information
- Founded
- WRLD 1962
- MDXG 2006
- Country
- WRLD United States
- MDXG United States
- Employees
- WRLD N/A
- MDXG N/A
- Industry
- WRLD Finance: Consumer Services
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- WRLD Finance
- MDXG Health Care
- Exchange
- WRLD Nasdaq
- MDXG Nasdaq
- Market Cap
- WRLD 825.5M
- MDXG 877.4M
- IPO Year
- WRLD 1991
- MDXG N/A
- Fundamental
- Price
- WRLD $162.31
- MDXG $6.79
- Analyst Decision
- WRLD
- MDXG Strong Buy
- Analyst Count
- WRLD 0
- MDXG 2
- Target Price
- WRLD N/A
- MDXG $11.50
- AVG Volume (30 Days)
- WRLD 64.1K
- MDXG 882.8K
- Earning Date
- WRLD 07-24-2025
- MDXG 07-30-2025
- Dividend Yield
- WRLD N/A
- MDXG N/A
- EPS Growth
- WRLD 10.94
- MDXG N/A
- EPS
- WRLD 14.92
- MDXG 0.27
- Revenue
- WRLD $567,706,378.00
- MDXG $352,375,000.00
- Revenue This Year
- WRLD N/A
- MDXG $9.55
- Revenue Next Year
- WRLD N/A
- MDXG $11.43
- P/E Ratio
- WRLD $10.66
- MDXG $25.08
- Revenue Growth
- WRLD 0.80
- MDXG 5.34
- 52 Week Low
- WRLD $101.85
- MDXG $5.47
- 52 Week High
- WRLD $177.25
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- WRLD 48.58
- MDXG 55.35
- Support Level
- WRLD $147.44
- MDXG $6.57
- Resistance Level
- WRLD $172.64
- MDXG $6.99
- Average True Range (ATR)
- WRLD 6.09
- MDXG 0.30
- MACD
- WRLD -1.73
- MDXG 0.02
- Stochastic Oscillator
- WRLD 49.88
- MDXG 75.24
About WRLD World Acceptance Corporation
World Acceptance Corp operates a small-loan consumer finance business. The company offers short-term small installment loans, medium-term larger installment loans, related credit insurance and ancillary products and services to individuals. It also offers income tax return preparation services to its loan customers and other individuals. The Company operates 1,024 branches in Alabama, Georgia, Idaho, Illinois, Indiana, Kentucky, Louisiana, Mississippi, Missouri, New Mexico, Oklahoma, South Carolina, Texas, Tennessee, Utah, and Wisconsin.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.